Reliability and Validity of the Selective Control of the Upper Extremity Scale in Stroke Patients

Launched by FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL · Nov 25, 2022

Keywords

ClinConnect Summary

According to the definition of the World Health Organization, stroke is a clinical syndrome characterized by rapid localization of the signs and symptoms of focal cerebral function loss for no apparent reason other than vascular causes, and the findings last longer than 24 hours. It is the second leading cause of death in the world. and is one of the most common causes of adult-onset disability.

Motor Control is defined as the ability to regulate or direct the mechanisms and systems necessary for the realization of movement. Coordinated contraction and relaxation of muscle groups in humans...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Being between the ages of 18-75
• • 2. History of unilateral ischemic or hemorrhagic stroke documented by cranial CT or MRI
• • 3. At least 6 months have passed since the stroke
• • 4. Upper extremity involvement between Brunnstrom stages 1 and 6
• • 5. To be voluntarily accepting the process
• Exclusion Criteria:
• • 1. Presence of additional diseases with progressive neurological deficit such as multiple sclerosis, amyotrophic lateral sclerosis
• • 2. Having additional muscle disease
• • 3. History of previous upper extremity surgery
• • 4. Botulinum toxin for spasticity treatment in the last 3 months
• • 5. Active localized or systemic infection
• • 6. Presence of diagnosed lymphedema in the upper extremities
• • 7. Having other neurological disorder affecting the upper extremity like brachial plexopathy etc.
• • 8. History of malignancy